UMB Bank’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $230K | Buy |
2,541
+117
| +5% | +$9.8K | ﹤0.01% | 694 |
|
|
2026
Q1 | $194K | Sell |
2,424
-137
| -5% | -$11.3K | ﹤0.01% | 704 |
|
|
2025
Q4 | $218K | Buy |
2,561
+101
| +4% | +$8.29K | ﹤0.01% | 658 |
|
|
2025
Q3 | $191K | Sell |
2,460
-559
| -19% | -$43.7K | ﹤0.01% | 632 |
|
|
2025
Q2 | $236K | Buy |
3,019
+96
| +3% | +$7.16K | ﹤0.01% | 564 |
|
|
2025
Q1 | $212K | Sell |
2,923
-1,837
| -39% | -$131K | ﹤0.01% | 565 |
|
|
2024
Q4 | $352K | Sell |
4,760
-4,906
| -51% | -$343K | 0.01% | 463 |
|
|
2024
Q3 | $638K | Sell |
9,666
-111,752
| -92% | -$8.12M | 0.01% | 374 |
|
|
2024
Q2 | $11.2M | Buy |
121,418
+3,760
| +3% | +$333K | 0.18% | 106 |
|
|
2024
Q1 | $11.2M | Buy |
117,658
+47,130
| +67% | +$3.96M | 0.18% | 110 |
|
|
2023
Q4 | $5.38M | Buy |
70,528
+58,737
| +498% | +$4.09M | 0.08% | 160 |
|
|
2023
Q3 | $817K | Sell |
11,791
-4,791
| -29% | -$385K | 0.01% | 345 |
|
|
2023
Q2 | $1.56M | Sell |
16,582
-297
| -2% | -$25.8K | 0.02% | 283 |
|
|
2023
Q1 | $1.4M | Sell |
16,879
-2,533
| -13% | -$199K | 0.02% | 296 |
|
|
2022
Q4 | $1.45M | Sell |
19,412
-19,310
| -50% | -$1.49M | 0.02% | 293 |
|
|
2022
Q3 | $3.2M | Sell |
38,722
-100,443
| -72% | -$9.66M | 0.05% | 207 |
|
|
2022
Q2 | $13.2M | Buy |
139,165
+3,903
| +3% | +$404K | 0.21% | 106 |
|
|
2022
Q1 | $15.9M | Sell |
135,262
-135,736
| -50% | -$15.2M | 0.21% | 106 |
|
|
2021
Q4 | $35.1M | Buy |
270,998
+28,151
| +12% | +$3.28M | 0.44% | 55 |
|
|
2021
Q3 | $27.5M | Buy |
242,847
+5,133
| +2% | +$586K | 0.62% | 40 |
|
|
2021
Q2 | $24.6M | Sell |
237,714
-258
| -0.1% | -$24.3K | 0.56% | 45 |
|
|
2021
Q1 | $19.9M | Buy |
237,972
+9,555
| +4% | +$808K | 0.49% | 53 |
|
|
2020
Q4 | $20.8M | Buy |
228,417
+173,165
| +313% | +$14.4M | 0.56% | 47 |
|
|
2020
Q3 | $3.82M | Hold |
55,252
| – | – | 0.12% | 133 |
|
|
2020
Q2 | $3.82M | Buy |
+55,252
| New | +$3.93M | 0.12% | 133 |
|
|
2017
Q1 | – | Sell |
-91,497
| Closed | -$2.86M | – | 338 |
|
|
2016
Q4 | $2.86M | Buy |
91,497
+8,622
| +10% | +$279K | 0.11% | 139 |
|
|
2016
Q3 | $3.33M | Sell |
82,875
-11,820
| -12% | -$445K | 0.13% | 129 |
|
|
2016
Q2 | $3.15M | Buy |
94,695
+40,077
| +73% | +$1.37M | 0.13% | 130 |
|
|
2016
Q1 | $1.61M | Buy |
+54,618
| New | +$1.51M | 0.07% | 165 |
|
Other funds holding EW
UMB Bank's EW Position: Q2 2026 in Review
UMB Bank increased its Edwards Lifesciences (EW) stake by 4.8% in Q2 2026, buying an estimated $9.8K and bringing the position to 2,541 shares worth $230K. The position accounts for ﹤0.01% of the portfolio, ranked #694.
UMB Bank first reported a position in EW in Q1 2016 and has held it in 29 quarters since. The position peaked at $35.1M in Q4 2021. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- UMB Bank held 2,541 shares of Edwards Lifesciences worth $230K as of Q2 2026.
- UMB Bank bought 117 Edwards Lifesciences shares in Q2 2026, an estimated $9.8K.
- Edwards Lifesciences made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #694 holding.
- UMB Bank first reported a position in Edwards Lifesciences in Q1 2016 and has held it in 29 quarters since.
- UMB Bank's Edwards Lifesciences position peaked at $35.1M in Q4 2021.
- 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.